Medpace Holdings, Inc. (MEDP) trades at a trailing P/E of 31.9, forward P/E of 30.3. Trailing earnings yield is 3.13%, forward earnings yield 3.30%. PEG 1.52. Graham Number is $76.30.
Criteria proven by this page:
Overall SharesGrow Score: 65/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 95.9 | -0.41 | 2.11 | 3.05 | - |
| 2017 | 36.2 | 0.22 | 2.81 | 3.25 | - |
| 2018 | 25.7 | 0.24 | 3.19 | 2.67 | - |
| 2019 | 30.0 | 0.83 | 4.15 | 3.50 | - |
| 2020 | 34.1 | 0.74 | 6.16 | 5.36 | - |
| 2021 | 42.9 | 1.76 | 8.19 | 6.83 | - |
| 2022 | 28.0 | 0.57 | 17.80 | 4.71 | - |
| 2023 | 33.3 | 1.55 | 16.85 | 4.99 | - |
| 2024 | 25.4 | 0.61 | 12.46 | 4.88 | - |
| 2025 | 35.9 | 1.82 | 35.29 | 6.40 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $0.37 | $421.58M | $13.43M | 3.2% |
| 2017 | $0.98 | $436.15M | $39.12M | 9% |
| 2018 | $1.97 | $704.59M | $73.19M | 10.4% |
| 2019 | $2.67 | $860.97M | $100.44M | 11.7% |
| 2020 | $3.84 | $925.93M | $145.38M | 15.7% |
| 2021 | $4.81 | $1.14B | $181.85M | 15.9% |
| 2022 | $7.28 | $1.46B | $245.37M | 16.8% |
| 2023 | $8.88 | $1.89B | $282.81M | 15% |
| 2024 | $12.63 | $2.11B | $404.39M | 19.2% |
| 2025 | $15.28 | $2.53B | $451.12M | 17.8% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $17.14 | $17.00 – $17.30 | $2.81B | $2.79B – $2.83B | 9 |
| 2027 | $19.04 | $18.40 – $19.47 | $3.01B | $2.86B – $3.16B | 8 |
| 2028 | $21.72 | $20.27 – $23.89 | $3.31B | $3.3B – $3.31B | 9 |
| 2029 | $24.00 | $22.48 – $25.14 | $3.63B | $3.45B – $3.76B | 3 |
| 2030 | $25.05 | $23.46 – $26.24 | $3.86B | $3.67B – $4B | 3 |
